N-Sulfonyl-β-lactam hapten as an effective labeling reagent for aldolase mAb
- PMID: 25791455
- PMCID: PMC4527526
- DOI: 10.1016/j.bmcl.2015.03.011
N-Sulfonyl-β-lactam hapten as an effective labeling reagent for aldolase mAb
Abstract
Utilization of chemically programmed antibodies (cpAbs) is regarded to be one of the most efficient methods for the development of therapeutic systems. cpAbs can extend the half-life of programming reagents, activate immune systems via the Fc region of antibodies and achieve universal vaccination by attaching varieties of small, programmed molecules. In the current study, we aimed to develop a novel labeling reagent for the preparation of cpAbs and found that N-sulfonyl-β-lactams (NSBLs) were optimal. NSBL can be synthesized from readily available 4-(bromomethyl)benzenesulfonyl chloride via few simple manipulations and can label the aldolase monoclonal antibody (mAb) 84G3, which could not be labeled effectively by the conventional labeling reagent, N-acyl-β-lactam (NABL). We also demonstrated that the conjugate, which consists of mAb 84G3 and an NSBL bearing a biotin moiety, maintained strong binding activity to streptavidin. In addition, the stability assay of NSBL revealed that NSBLs can tolerate aqueous media without significant decomposition over 24h.
Keywords: Aldolase antibody; Bioconjugation; Chemically programmed antibody; N-Sulfonyl-β-lactam.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Figures
References
-
- Alley SC, Okeley NM, Senter PD. Curr Opin Chem Biol. 2010;14:529. - PubMed
-
- Carter PJ, Senter PD. Cancer J. 2008;14:154. - PubMed
-
- Zhou D. Biochem Soc Trans. 2012;40:635. - PubMed
-
- Czlapinski JL, Sheppard TL. J Am Chem Soc. 2001;123:8618. - PubMed
-
- Singh KV, Kaur J, Varshney GC, Raje M, Suri CR. Bioconjugate Chem. 2004;15:168. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
